Devil’s Claw (Harpagophytum procumbens DC)

References

• Chrubasik S, Sporer F, Wink M. Content of active substance in tea preparations from Harpagophytum procumbens. Forsch Komplementarmed 1996; 3: 116–119
   Google Scholar
• Chrubasik S, Sporer F, Wink M, et al. Zum wirkstoffgehalt in arzneimitteln aus harpagophytum procumbens. Forsch Komplementärmed 1996; 3: 57–63
   Google Scholar
• Chrubasik S, Zimpfer C, Schutt U, et al. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 1996; 3(1)1–10
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Junck H, Breitschwerdt H, et al. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind study. Eur J Anaesthesiol 1999; 16(2)118–129
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Eisenberg E. Treatment of rheumatic pain with Kampo medicine in Europe. The Pain Clinic 1999; 11(3)171
   Web of Science ®Google Scholar
• Circosta C, Occhiuto F, Ragusa S, et al. A drug used in traditional medicine: Harpagophytum procumbens DC. II. Cardiovascular activity. J Ethnopharmacol 1984; 11(3)259–274
   PubMed Web of Science ®Google Scholar
• Costa De Pasquale R, Busa G, Circosta C, et al. A drug used in traditional medicine: Harpagophytum procumbens DC. III. Effects on hyperkinetic ventricular arrhythmias by reperfusion. J Ethnopharmacol 1985; 13(2)193–199
   PubMed Web of Science ®Google Scholar
• Pourrat H, Texier O, Vennat B, et al. Stability of iridoids of Harpagophytum procumbens DC. during the preparation of powders and atomized drugs. Ann Pharm Fr 1985; 43(6)601–606
   PubMed Web of Science ®Google Scholar
• Baranska M, Schulz H, Siuda R, et al. Quality control of Harpagophytum procumbens and its related phytopharmaceutical products by means of NIR-FT-Raman spectroscopy. Biopolymers 2005; 77(1)1–8
   PubMed Web of Science ®Google Scholar
• Chrubasik S. Addendum to the ESCOP monograph on Harpagophytum procumbens. Phytomedicine 2004; 11(7–8)691–695
   PubMedGoogle Scholar
• Chrubasik S. Devil’s claw extract as an example of the effectiveness of herbal analgesics. Orthopade 2004; 33(7)804–808
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Conradt C, Roufogalis B D. Effectiveness of Harpagophytum extracts and clinical efficacy. Phytother Res 2004; 18(2)187–189
   PubMed Web of Science ®Google Scholar
• Van Haelen M, van Haelen-Fastré R, Samaey-Fontaine J, et al. Aspects botaniques, constitution chimique et activité pharmacologique d’Harpagophytum procumbens. Phytotherapy 1983; 5: 7–13
   Google Scholar
• Erdos A, Fontaine R, Friehe H, et al. Contribution to the pharmacology and toxicology of different extracts as well as the harpagosid from Harpagophytum procumbens DC. Planta Med 1978; 34(1)97–108
   PubMed Web of Science ®Google Scholar
• Whitehouse L W, Znamirowska M, Paul C J. Devil’s Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J 1983; 129(3)249–251
   PubMed Web of Science ®Google Scholar
• Zimmermann W. Pflanzliche Bitterstoffe in der Gastroenterologie. Z Allgemeinmed 1976; 23: 1178–1184
   Google Scholar
• Grahame R, Robinson B V. Devils’s claw (Harpagophytum procumbens): pharmacological and clinical studies. Ann Rheum Dis 1981; 40(6)632
   PubMed Web of Science ®Google Scholar
• Belaiche P. Etude clinique de 630 cas d’artrose traites par le nebulisat aqueux d’Harpagophytum procumbens (Radix). Phytotherapy 1982; 1: 22–28
   Google Scholar
• Chantre P, Cappelaere A, Leblan D, et al. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000; 7(3)177–183
   PubMed Web of Science ®Google Scholar
• Shaw D, Leon C, Kolev S, et al. Traditional remedies and food supplements. A 5-year toxicological study (1991–1995). Drug Saf 1997; 17(5)342–356, View Abstract
   PubMed Web of Science ®Google Scholar
• Heck A M, DeWitt B A, Lukes A L. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000; 57(13)1221–1227, View Abstract
   PubMed Web of Science ®Google Scholar
• Kikuchi T. New iridoid glucosides from Harpagophytum procumbens. Chem Pharm Bull 1983; 31: 2296–2301
   Web of Science ®Google Scholar
• Tunmann P, Lux R. Zur Kenntnis der Inhaltsstoffe aus der Wurzel von Harpagophytum procumbens DC. DAZ 1962; 102(40)1274–1275
   Google Scholar
• Ficarra P, Ficarra R, Tommasini A, et al. [HPLC analysis of a drug in traditional medicine: Harpagophytum procumbens DC. I]. Boll Chim Farm 1986; 125(7)250–253
   PubMedGoogle Scholar
• Boje K, Lechtenberg M, Nahrstedt A. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 2003; 69(9)820–825
   PubMed Web of Science ®Google Scholar
• Munkombwe N M. Acetylated phenolic glycosides from Harpagophytum procumbens. Phytochemistry 2003; 62(8)1231–1234
   PubMed Web of Science ®Google Scholar
• Tunmann P, Bauersfeld H J. Über weitere Inhaltsstoffe der Wurzel von Harpagophytum procumbens DC. Arch Pharm (Weinheim) 1975; 308(8)655–657
   PubMed Web of Science ®Google Scholar
• Benito P M, Lanza A M, Sen A M, et al. Effects of some iridoids from plant origin on arachidonic acid metabolism in cellular systems. Planta Med 2000; 66(4)324–328
   PubMed Web of Science ®Google Scholar
• Loew D, Mollerfeld J, Schrodter A, et al. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin Pharmacol Ther 2001; 69(5)356–364
   PubMed Web of Science ®Google Scholar
• Moussard C, Alber D, Toubin M M, et al. A drug used in traditional medicine, Harpagophytum procumbens: no evidence for NSAID-like effect on whole blood eicosanoid production in human. Prostaglandins Leukot Essent Fatty Acids 1992; 46(4)283–286
   PubMed Web of Science ®Google Scholar
• Kaszkin M, Beck K F, Koch E, et al. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 2004; 11(7–8)585–595
   PubMed Web of Science ®Google Scholar
• Fiebich B L, Heinrich M, Hiller K O, et al. Inhibition of TNF-alpha synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 2001; 8(1)28–30
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Fiebich B, Black A, et al. Treating low back pain with an extract of Harpagophytum procumbens that inhibits cytokine release. Eur J Anaesthesiol 2002; 19: 209
   Google Scholar
• Jang M H, Lim S, Han S M, et al. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 2003; 93(3)367–371
   PubMed Web of Science ®Google Scholar
• Kundu J K, Mossanda K S, Na H K, et al. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC. on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett 2005; 218(1)21–31
   PubMed Web of Science ®Google Scholar
• Na H K, Mossanda K S, Lee J Y, et al. Inhibition of phorbol ester-induced COX-2 expression by some edible African plants. Biofactors 2004; 21(1–4)149–153
   PubMed Web of Science ®Google Scholar
• Schulze-Tanzil G, Hansen C, Shakibaei M. [Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro]. Arzneimittelforschung 2004; 54(4)213–220
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Bhattacharya S K. Anti-oxidative activity of Harpagophytum procumbens. Br J Phytother 1998; 72: 68–71
   Google Scholar
• Langmead L, Dawson C, Hawkins C, et al. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther 2002; 16(2)197–205
   PubMed Web of Science ®Google Scholar
• Jadot G, Lecomte A. Activite anti-inflammatoire d’Harpagophytum procumbens DC. Lyon Mediteranee Med Sud-Est 1992; 28: 833–835
   Google Scholar
• Betancor-Fernandez A, Perez-Galvez A, Sies H, et al. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil’s claw root and garlic or salmon oil for antioxidant capacity. J Pharm Pharmacol 2003; 55(7)981–986
   PubMed Web of Science ®Google Scholar
• Fontaine J, Elchami A A, Vanhaelen M, et al. [Biological analysis of Harpagophytum procumbens D.C. II. Pharmacological analysis of the effects of harpagoside, harpagide and harpagogenine on the isolated guinea-pig ileum (editor’s transl)]. J Pharm Belg 1981; 36(5)321–324
   PubMed Web of Science ®Google Scholar
• Occhiuto F, Circosta C, Ragusa S, et al. A drug used in traditional medicine: Harpagophytum procumbens DC. IV. Effects on some isolated muscle preparations. J Ethnopharmacol 1985; 13(2)201–208
   PubMed Web of Science ®Google Scholar
• Clarkson C, Campbell W E, Smith P. In vitro antiplasmodial activity of abietane and totarane diterpenes isolated from Harpagophytum procumbens (devil’s claw). Planta Med 2003; 69(8)720–724
   PubMed Web of Science ®Google Scholar
• Eichler O, Koch C. [Antiphlogistic, analgesic and spasmolytic effect of harpagoside, a glycoside from the root of Harpagophytum procumbens DC]. Arzneimittelforschung 1970; 20(1)107–109
   PubMed Web of Science ®Google Scholar
• Lanhers M C, Fleurentin J, Mortier F, et al. Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med 1992; 58(2)117–123
   PubMed Web of Science ®Google Scholar
• McLeod D W, Revell P, Robinson B V. Investigations of Harpagophytum procumbens (Devil’s Claw) in the treatment of experimental inflammation and arthritis in the rat [proceedings]. Br J Pharmacol 1979; 66(1)140P–141P
   PubMed Web of Science ®Google Scholar
• Baghdikian B, Lanhers M C, Fleurentin J, et al. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med 1997; 63(2)171–176
   PubMed Web of Science ®Google Scholar
• Andersen M L, Santos E H, Seabra M L, et al. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund’s adjuvant-induced arthritis in rats. J Ethnopharmacol 2004; 91(2–3)325–330
   PubMed Web of Science ®Google Scholar
• Ernst E, Chrubasik S. Phyto-anti-inflammatories. A systematic review of randomized, placebo-controlled, double-blind trials. Rheum Dis Clin North Am 2000; 26(1)13–27
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Sporer F, Dillmann-Marschner R, et al. Physicochemical properties of harpagoside and its in vitro release from Harpagophytum procumbens extract tablets. Phytomedicine 2000; 6(6)469–473
   PubMed Web of Science ®Google Scholar
• Soulimani R, Younos C, Mortier F, et al. The role of stomachal digestion on the pharmacological activity of plant extracts, using as an example extracts of Harpagophytum procumbens. Can J Physiol Pharmacol 1994; 72(12)1532–1536
   PubMed Web of Science ®Google Scholar
• Loew D, Schuster O, Möllerfeld J. Stabilität und biopharmazeutische Qualität. Voraussetzung für Bioverfü gbarkeit von Harpagophytum procumbens. Phytopharmaka II. Forschung und klinische Anwendung, D Loew, N Rietbrock. Forschung und klinische Anwendung, Darmstadt 1996; 83–93
   Google Scholar
• Baghdikian B, Dauriac H, Ollivier E, et al. Formation of nitrogen-containing metabolites from the main iridoids of Harpagophytum procumbens and H. zeyheri by human intestinal bacteria. Planta Med 1999; 65(2)164–166, View Abstract
   PubMed Web of Science ®Google Scholar
• Guyader M. Les plantes antirhumatismales. Etude historique et pharmacologique, et etude clinique du nebulisat d’Harpagohytum procumbens DC chez 50 patients arthrosiques suivis en service hospitalier [Dissertation]. Universite Pierre et Marie Curie. 1984
   Google Scholar
• Lecomte A, Costa J P. Harpagophytum dans l’arthrose: Etude en double insu contre placebo. Le Magazine 1992; 15: 27–30
   Google Scholar
• Pinget M, Lecompte A. Etude des effets de l’harpagophytum en rhumatologie dégénérative. 37 Le magazine 1990, 10: 1–10
   Google Scholar
• Schrüffer H. Salus Teufelskralle-Tabletten. Ein Fortschritt in der nichtsteroidalen antirheumatischen Therapie. Die Medizinische Publikation 1980; 1: 1–8
   Google Scholar
• Frerick H, Biller A, Schmidt U. Stufenschema bei Coxarthrose. Der Kassenarzt 2001; 5(34)41
   Google Scholar
• Schmelz H, Haemmerle H D, Springorum H W. Analgetische Wirksamkeit eines Teufels-krallenwurzel-Extraktes bei verschiedenen chronisch-degenerativen Gelenkerkrankungen. Rheumatherapie mit Phytopharmaka, S Chrubasik, M Wink. Hippokrates, Stuttgart 1997; 86–89
   Google Scholar
• Ribbat J M, Schakau D. Behandluing chronisch aktivierter Schmerzen am Bewegungsapparat. NaturaMed 2001; 16: 23–30
   Google Scholar
• Wegener T, Lupke N P. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil’s claw (Harpagophytum procumbens DC.). Phytother Res 2003; 17(10)1165–1172
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Sporer F, Wink M. Harpagoside content of different powdered dry extracts from Harpagophytum procumbens. Forsch Komplmentarmed 1996; 3: 6–11
   Google Scholar
• Gobel H, Heinze A, Ingwersen M, et al. Effects of Harpagophytum procumbens LI 174 (devil’s claw) on sensory, motor und vascular muscle reagibility in the treatment of unspecific back pain. Schmerz 2001; 15(1)10–18
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Schmidt A, Junck H, et al. Effectiveness and economy of Harpagophytum extract in the treatment of acute low back pain-first results of a therapeutic cohort study. Forsch Komplementarmed 1997; 4: 332–336
   Google Scholar
• Laudahn D, Walper A. Efficacy and tolerance of Harpagophytum extract LI 174 in patients with chronic non-radicular back pain. Phytother Res 2001; 15(7)621–624
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Model A, Black A, et al. A randomized double-blind pilot study comparing Doloteffin(r) and Vioxx(r) in the treatment of low back pain. Rheumatology 2003; 42: 141–148
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Conradt C, Black A. The quality of clinical trials with Harpagophytum procumbens. Phytomedicine 2003; 10(6–7)613–623
   PubMed Web of Science ®Google Scholar